CardioDx Lands $57,491,448 New Financing

  • Feed Type
  • Date
    3/7/2011
  • Company Name
    CardioDx
  • Mailing Address
    2500 Faber Place Palo Alto, CA 94303
  • Company Description
    Founded in 2004, CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure.
  • Website
    http://www.cardiodx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $57,491,448
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Transaction amount assumes the exercise of warrants of $3,359,837.
  • M&A Terms
  • Venture Investor
    Longitude Capital Management
  • Venture Investor
    Undisclosed

Trending on Xconomy